IP Library Granted Patent US 7,732,127
Granted Patent B2
US 7,732,127 · App. 11/235,938 · Granted Jun 8, 2010

Dynamic monitoring of cell adhesion and spreading using the RT-CES system

Assignee: ACEA Biosciences, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,732,127
App. No.
11/235,938
Granted
Jun 8, 2010
Kind
B2
Abstract

The present invention includes devices and methods for dynamically monitoring cell adhesion and cell spreading. Cells are added to a microelectronic cell sensor array operably connected to an impedance analyzer. The device also includes a coating including biological molecule or organic compound capable of interacting with the cell. Cell adhesion and cell mobility is determined by detecting changes in impedance and comparing impedance or cell index values between samples.

Claims (20)

1. A method of monitoring cell adhesion or cell spreading comprising:

a) providing a device operably connected to an impedance analyzer; said device comprising:

i) a non-conductive substrate,

ii) a plurality of electrode arrays and at least two connection pads positioned on said substrate, wherein each electrode array comprises at least two electrode structures, each of which comprises multiple electrode elements, further wherein the electrode structures of each electrode array have substantially the same surface area and are fabricated on a same side of said substrate, further wherein the electrode elements of each electrode structure of an electrode array are connected together to a common connection pad; and

iii) a test portion of said substrate coated with a test biological molecule or an organic compound, and a control portion of said substrate optionally coated with a biological molecule or organic compound, wherein each molecule or compound is independently selected from the group consisting of a DNA molecule, an RNA molecule, a protein, a polypeptide, an oligopeptide, an antibody, a ligand, a peptide, a receptor, one or more proteins or compounds present in the extracellular matrix (ECM), a molecule or compound capable of binding an integrin, and a cell surface receptor;

b) introducing a cell or cell population to said test portion and to said control portion;

c) performing a series of impedance measurements of said test portion and said control portion;

d) determining the change in impedance and optionally a cell index (CI) of said test portion and the change in impedance and optionally a cell index (CI) of said control portion;

e) comparing said change in impedance of said test portion to said change in impedance of said control portion or comparing said cell index (CI) of said test portion to said cell index (CI) of said control portion; and

f) determining whether cell adhesion or cell spreading on the test portion is different from that on the control portion if said comparison demonstrates a significant change in impedance.

2. The method according to claim 1 , wherein said device comprises at least two test portions, wherein said biological molecule or said organic compound is positioned on said at least two test portions optionally in different concentrations, further wherein said impedance measurement is performed for each of said at least two test portions and said change in impedance and optionally said cell index (CI) is determined for each of said at least two test portions.

3. The method according to claim 1 , wherein said at least two test portions are at least two test wells and said control portion is a control well, wherein said at least two test wells and said control well are perpendicularly oriented to a longitudinal axis.

4. The method according to claim 1 , wherein said cell is a eukaryotic cell or said cell population is a eukaryotic cell population.

5. The method according to claim 4 , wherein said eukaryotic cell is a human cell or said eukaryotic cell population is a human cell population.

6. The method according to claim 1 , wherein said cell is a B-lymphocyte, T-lymphocyte or other immune cell or said cell population is a B-lymphocyte population, T-lymphocyte population or other immune cell population.

7. The method according to claim 1 , wherein said series of measurements are performed at regular time intervals.

8. The method according to claim 1 , wherein said series of measurements are performed at irregular time intervals.

9. The method according to claim 1 , wherein said compound or biological molecule is capable of effecting cell adhesion or spreading if said comparison demonstrates a significant change in impedance.

10. The method according claim 9 , wherein said biological compound or organic compound increases cell spreading or cell adhesion if change in impedance of said test portion is significantly greater than that of said control portion.

11. The method according claim 9 , wherein said biological compound or organic compound is an inhibitor if change in impedance of said control portion is significantly greater than that of said test portion.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2021
From: ACEA BIOSCIENCES, INC.
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 055409/0874 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME FROM ACEA BIOSCIENCES CORPORATION TO ACEA BIOSCIENCES, INC. PREVIOUSLY RECORDED ON REEL 017566 FRAME 0389. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECTION FROM ACEA BIOSCIENCES CORPORATION (ASSIGNEE)TO ACEA BIOSCIENCES, INC. (ASSIGNEE). Recorded Mar 26, 2010
From: ABASSI, YAMA A.; ATIENZA, JOSEPHINE; WANG, XIAOBO; XU, XIAO
To: ACEA BIOSCIENCES, INC.
Reel/Frame 024148/0518 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2006
From: ABASSI, YAMA A.; ATIENZA, JOSEPHINE; WANG, XIAOBO; XU, XIAO
To: ACEA BIOSCIENCES CORPORATION
Reel/Frame 017566/0389 →
Continuity (40)
Continuation In Part 1119799400 · Aug 4, 2005
Continuation In Part 1105563900 · Feb 9, 2005
Continuation In Part 1098773200 · Nov 12, 2004
Continuation In Part 1070544700 · Nov 10, 2003
Continuation PCTUS032255700 · Jul 18, 2003
Continuation 1123593800
Continuation In Part PCTUS200502794300 · Aug 4, 2005
Continuation In Part PCTUS200502789100 · Aug 4, 2005
Continuation In Part 1070561500 · Nov 10, 2003
Continuation PCTUS032253700 · Jul 18, 2003
Continuation In Part PCTUS200500448100 · Feb 9, 2005
Continuation In Part PCTUS200403769600 · Nov 12, 2004
Provisional Application 6051956700 · Nov 12, 2003
Provisional Application 6039774900 · Jul 20, 2002
Provisional Application 6043540000 · Dec 20, 2002
Provisional Application 6046957200 · May 9, 2003
Provisional Application 6063013100 · Nov 22, 2004
Provisional Application 6063007100 · Nov 22, 2004
Provisional Application 6061387200 · Sep 27, 2004
Provisional Application 6061374900 · Sep 27, 2004
Provisional Application 6063080900 · Nov 24, 2004
Provisional Application 6063301900 · Dec 3, 2004
Provisional Application 6064715900 · Jan 26, 2005
Provisional Application 6065390400 · Feb 27, 2005
Provisional Application 6067367800 · Apr 25, 2005
Provisional Application 6068942200 · Jun 10, 2005
Provisional Application 6039774900 · Jul 20, 2002
Provisional Application 6043540000 · Dec 20, 2002
Provisional Application 6046957200 · May 9, 2003
Provisional Application 6054292700 · Feb 9, 2004
Provisional Application 6054871300 · Feb 27, 2004
Provisional Application 6061460100 · Sep 29, 2004
Provisional Application 6059860800 · Aug 4, 2004
Provisional Application 6059860900 · Aug 4, 2004
Provisional Application 6061374900 · Sep 27, 2004
Provisional Application 6067418900 · Jan 26, 2005
Provisional Application 6064707500 · Jan 26, 2005
Provisional Application 6066082900 · Mar 10, 2005
Provisional Application 6066089800 · Mar 10, 2005
Related Publication 20060120204A1 · Jun 8, 2006